D
Daniel L. Kong
Researcher at Harvard University
Publications - 4
Citations - 339
Daniel L. Kong is an academic researcher from Harvard University. The author has contributed to research in topics: Thromboxane & Prostacyclin. The author has an hindex of 4, co-authored 4 publications receiving 337 citations.
Papers
More filters
Journal ArticleDOI
Role of Thromboxane and Prostacyclin in Pulmonary Vasomotor Changes after Endotoxin in Dogs
TL;DR: A complex interaction between thromboxane and prostacyclin is involved in the pulmonary vasomotor response to low-dose endotoxin and Indomethacin prevented the rise in throm boxane and Prostaglandin after endotoxin as well as the changes in pulmonary vasodilator tone.
Journal ArticleDOI
Thromboxane and prostacyclin changes during cardiopulmonary bypass with and without pulsatile flow.
W.David Watkins,Myron B. Peterson,Daniel L. Kong,Katsuakira Kono,Mortimer J. Buckley,Frederick H. Levine,Daniel M. Philbin +6 more
TL;DR: Pulsatile flow significantly alters prostacyclin and thromboxane profiles during cardiopulmonary bypass and favors production of the coronary vasodilator and platelet disaggregant prostacy Clin.
Journal ArticleDOI
Thromboxane and pulmonary hypertension following E. coli endotoxin infusion in sheep: Effect of an imidazole derivative
TL;DR: Evidence is provided that endotoxin-induced pulmonary hypertension is mediated by pulmonary synthesis of TxA2, and peak concentrations of 6-keto-PGF1 alpha (PGI2) and PGF2 alpha were severalfold higher than those measured in control animals.
Journal ArticleDOI
Prostaglandin response to intravenous nitroglycerin.
William C. Nugent,Marja-Tellervo Nieminen,Christos D. Liapis,W.David Watkins,Daniel L. Kong,Myron B. Peterson,Daniel M. Philbin,Frederick H. Levine +7 more
TL;DR: The data demonstrate that the action of TNG is not mediated by prostacyclin, and TNG infusion does result in an initial significant thromboxane release in the myocardial circulation which can be blocked by ibuprofen.